Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In vivo activity of a novel regimen of capecitabine (C) in a breast cancer xenograft model
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Higgins, B.; Kolinsky, K.; Packman, K.; Dugan, U.; Hudis, C. A.; Norton, L.
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Optimizing chemotherapy administration: A phase I study of biweekly capecitabine dose and schedule based on Norton-Simon mathematical modeling
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Panageas, K.; Hodgman, E.; Norton, L.; Hudis, C. A.
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Letrozole (L) with bevacizumab (B) is feasible in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Rugo, H.; Caravelli, J.; Yeh, B.; Panageas, K.; Bruckner, J.; Norton, L.; Park, J.; Hudis, C.; Dickler, M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Has demand outpaced supply for clinical trial participants?
    Meeting Abstract

    Tam, J. T.; Hauser, R.; Gura, D.; Paraghamian, A.; Thomas, H.; Lichtman, S.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    Meeting Abstract

    Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • A phase II study of single agent depsipeptide (DEP) in patients (pts) with radio-active iodine (RAI)-refractory, metastatic, thyroid carcinoma: Preliminary toxicity and efficacy experience
    Meeting Abstract

    Su, Y. B.; Tuttle, R. M.; Fury, M.; Ghossein, R.; Singh, B.; Herman, K.; Venkatraman, E. S.; Stambuk, H.; Robbins, R.; Pfister, D. G.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Ductal carcinoma in situ and BRCA mutations: Association and risk factors
    Meeting Abstract

    Smith, K. L.; Adank, M.; Kauff, N.; Lafaro, K.; Boyd, J.; Lee, J.; Hudis, C.; Offit, K.; Robson, M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Validation of flow cytometric measurements of NK cytotoxicity against chromium release assay for use in clinical monitoring of immune function
    Meeting Abstract

    Smith, K.; Heller, G.; Maslak, P.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of rituximab for the prevention of Epstein Barr virus B cell lymphoproliferative disorder (EBV-LPD) following T cell depleted (TCD) unrela ted or HLA-mismatched related hematopoietic stem cell transplantation
    Meeting Abstract

    Small, T. N.; Kernan, N. A.; Jakubowski, A.; Young, J. W.; Prockop, S.; Perales, M. A.; O'Reilly, R. J.; Papadopoulos, E. B.
    Blood (2006)

    Fulltext@MSK | Save
  • Phase I trial results of PCK3145 in patients (pts) with castrate metastatic prostate cancer (PC) - The US experience
    Meeting Abstract

    Slovin, S. F.; Daigneault, L.; Dulude, H.; Panchal, C.; Richardson, J.; Curley, T.; Delacruz, A.; Fleisher, M.; Morris, M.; Scher, H.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save